Business Description
Kewaunee Scientific Corp
NAICS : 333318
SIC : 3821
ISIN : US4928541048
Compare
Compare
Traded in other countries / regions
KEQU.USAKEW.Germany IPO Date
2007-09-05Description
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.16 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | 0.5 | |||||
| Interest Coverage | 6.42 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.34 | |||||
| Beneish M-Score | -8.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.1 | |||||
| 3-Year EBITDA Growth Rate | 233.2 | |||||
| 3-Year Book Growth Rate | 8.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.3 | |||||
| 9-Day RSI | 71.55 | |||||
| 14-Day RSI | 72.49 | |||||
| 6-1 Month Momentum % | -7.35 | |||||
| 12-1 Month Momentum % | 52.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.64 | |||||
| Quick Ratio | 2.13 | |||||
| Cash Ratio | 0.71 | |||||
| Days Inventory | 50.88 | |||||
| Days Sales Outstanding | 78.33 | |||||
| Days Payable | 51.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | 2.12 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.6 | |||||
| Operating Margin % | 6.15 | |||||
| Net Margin % | 9.39 | |||||
| FCF Margin % | 7.91 | |||||
| ROE % | 36.57 | |||||
| ROA % | 14.44 | |||||
| ROIC % | 24.04 | |||||
| ROC (Joel Greenblatt) % | 20.4 | |||||
| ROCE % | 14.45 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.83 | |||||
| PE Ratio without NRI | 9.24 | |||||
| Shiller PE Ratio | 62.46 | |||||
| Price-to-Owner-Earnings | 13.43 | |||||
| PEG Ratio | 0.15 | |||||
| PS Ratio | 0.92 | |||||
| PB Ratio | 3 | |||||
| Price-to-Tangible-Book | 3 | |||||
| Price-to-Free-Cash-Flow | 11.6 | |||||
| Price-to-Operating-Cash-Flow | 10.07 | |||||
| EV-to-EBIT | 12.31 | |||||
| EV-to-EBITDA | 9.86 | |||||
| EV-to-Revenue | 0.81 | |||||
| EV-to-FCF | 10.18 | |||||
| Price-to-Projected-FCF | 3.21 | |||||
| Price-to-Median-PS-Value | 2.5 | |||||
| Price-to-Graham-Number | 1.11 | |||||
| Price-to-Net-Current-Asset-Value | 8.37 | |||||
| Earnings Yield (Greenblatt) % | 8.12 | |||||
| FCF Yield % | 8.91 | |||||
| Forward Rate of Return (Yacktman) % | -35.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kewaunee Scientific Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 184.253 | ||
| EPS (TTM) (€) | 5.847 | ||
| Beta | -0.74 | ||
| Volatility % | 83.02 | ||
| 14-Day RSI | 72.49 | ||
| 14-Day ATR (€) | 2.1687 | ||
| 20-Day SMA (€) | 49.415 | ||
| 12-1 Month Momentum % | 52.42 | ||
| 52-Week Range (€) | 24.4 - 61.5 | ||
| Shares Outstanding (Mil) | 2.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kewaunee Scientific Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kewaunee Scientific Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kewaunee Scientific Corp Frequently Asked Questions
What is Kewaunee Scientific Corp(STU:KEW)'s stock price today?
The current price of STU:KEW is €58.50. The 52 week high of STU:KEW is €61.50 and 52 week low is €24.40.
When is next earnings date of Kewaunee Scientific Corp(STU:KEW)?
The next earnings date of Kewaunee Scientific Corp(STU:KEW) is 2025-03-07 Est..
Does Kewaunee Scientific Corp(STU:KEW) pay dividends? If so, how much?
Kewaunee Scientific Corp(STU:KEW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers